BC Global Opportunities IX LP - Sep 4, 2025 SCHEDULE 13G Report for BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT)

Filing Manager
BC Global Opportunities IX LP
Reporting Manager
BC Global Opportunities IX LP
Security
BridgeBio Oncology Therapeutics, Inc. Common Stock
Symbol
BBOT
Shares outstanding
79.4M shares
Disclosed Ownership
4.37M shares
Ownership
5.5%
Form type
SCHEDULE 13G
Date filed
9/3/2025, 03:05 PM
Date of event
Sep 4, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BC Global Opportunities IX LP 5.5% 4.37M 0 4.37M Freeman Szeto Operation Manager
BC General Partner, LP 5.5% 4.37M 0 4.37M Freeman Szeto Operation Manager
BC Capital Management Limited 5.5% 4.37M 0 4.37M Freeman Szeto Operation Manager
Tan Kuangming 5.5% 4.37M 0 4.37M Tan Kuangming Director